TrialSchizophrenia research2012

Rimonabant for neurocognition in schizophrenia: a 16-week double blind randomized placebo controlled trial.

Douglas L Boggs et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.